Xilong Scientific Co., Ltd. (SHE:002584)
China
· Delayed Price · Currency is CNY 9.73
+0.36 (3.84%)
May 16, 2025, 3:04 PM CST
Xilong Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 7,816 | 7,680 | 6,176 | 5,372 | 6,235 | Upgrade
|
Other Revenue | - | 13.73 | 7.27 | 8.12 | 8.18 | Upgrade
|
| Revenue | 7,816 | 7,693 | 6,183 | 5,380 | 6,243 | Upgrade
|
Revenue Growth (YoY) | 1.60% | 24.42% | 14.93% | -13.83% | 87.05% | Upgrade
|
Cost of Revenue | 7,281 | 7,234 | 5,756 | 4,856 | 5,787 | Upgrade
|
Gross Profit | 535.52 | 459.7 | 426.78 | 523.64 | 456.34 | Upgrade
|
Selling, General & Admin | 243.65 | 234.82 | 211.47 | 240.76 | 251.47 | Upgrade
|
Research & Development | 109.9 | 95.7 | 90.47 | 118.97 | 102.72 | Upgrade
|
Other Operating Expenses | -8.95 | 5.75 | 17.19 | 16.02 | 14.08 | Upgrade
|
Operating Expenses | 344.6 | 344.61 | 331.92 | 395.75 | 381.31 | Upgrade
|
Operating Income | 190.92 | 115.1 | 94.86 | 127.88 | 75.04 | Upgrade
|
Interest Expense | - | -60.86 | -49.08 | -67.5 | -65.09 | Upgrade
|
Interest & Investment Income | 1.22 | 6.7 | 92.1 | 144.18 | 12.52 | Upgrade
|
Currency Exchange Gain (Loss) | - | -4.38 | -9.5 | 1.3 | 17.89 | Upgrade
|
Other Non Operating Income (Expenses) | -106.37 | -15.1 | -29.59 | -7.76 | -3.56 | Upgrade
|
EBT Excluding Unusual Items | 85.77 | 41.46 | 98.79 | 198.11 | 36.79 | Upgrade
|
Impairment of Goodwill | - | -6.54 | - | - | -11.95 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 0 | - | -0.36 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.84 | 0.21 | -0.14 | -0.39 | 43.94 | Upgrade
|
Asset Writedown | -12.64 | -0.5 | -1.47 | 0.34 | -0.66 | Upgrade
|
Other Unusual Items | - | 8.29 | 5.57 | 11.04 | 13.49 | Upgrade
|
Pretax Income | 72.29 | 42.92 | 102.74 | 209.1 | 81.25 | Upgrade
|
Income Tax Expense | 9.3 | 8.33 | 15.04 | 7.98 | 17.56 | Upgrade
|
Earnings From Continuing Operations | 62.99 | 34.59 | 87.69 | 201.12 | 63.69 | Upgrade
|
Minority Interest in Earnings | -1.22 | -1.24 | 1.37 | -14.06 | -6.81 | Upgrade
|
Net Income | 61.77 | 33.35 | 89.06 | 187.06 | 56.87 | Upgrade
|
Net Income to Common | 61.77 | 33.35 | 89.06 | 187.06 | 56.87 | Upgrade
|
Net Income Growth | 85.24% | -62.56% | -52.39% | 228.91% | 47.62% | Upgrade
|
Shares Outstanding (Basic) | 562 | 556 | 594 | 534 | 569 | Upgrade
|
Shares Outstanding (Diluted) | 562 | 556 | 594 | 534 | 569 | Upgrade
|
Shares Change (YoY) | 1.04% | -6.39% | 11.09% | -6.02% | 3.33% | Upgrade
|
EPS (Basic) | 0.11 | 0.06 | 0.15 | 0.35 | 0.10 | Upgrade
|
EPS (Diluted) | 0.11 | 0.06 | 0.15 | 0.35 | 0.10 | Upgrade
|
EPS Growth | 83.33% | -60.00% | -57.14% | 250.00% | 42.86% | Upgrade
|
Free Cash Flow | 257.23 | -499.96 | -514.59 | 316.27 | 6.33 | Upgrade
|
Free Cash Flow Per Share | 0.46 | -0.90 | -0.87 | 0.59 | 0.01 | Upgrade
|
Dividend Per Share | - | 0.020 | - | - | - | Upgrade
|
Gross Margin | 6.85% | 5.97% | 6.90% | 9.73% | 7.31% | Upgrade
|
Operating Margin | 2.44% | 1.50% | 1.53% | 2.38% | 1.20% | Upgrade
|
Profit Margin | 0.79% | 0.43% | 1.44% | 3.48% | 0.91% | Upgrade
|
Free Cash Flow Margin | 3.29% | -6.50% | -8.32% | 5.88% | 0.10% | Upgrade
|
EBITDA | 238.8 | 152.21 | 130.97 | 157.56 | 104.93 | Upgrade
|
EBITDA Margin | 3.06% | 1.98% | 2.12% | 2.93% | 1.68% | Upgrade
|
D&A For EBITDA | 47.88 | 37.11 | 36.11 | 29.68 | 29.9 | Upgrade
|
EBIT | 190.92 | 115.1 | 94.86 | 127.88 | 75.04 | Upgrade
|
EBIT Margin | 2.44% | 1.50% | 1.53% | 2.38% | 1.20% | Upgrade
|
Effective Tax Rate | 12.86% | 19.41% | 14.64% | 3.82% | 21.61% | Upgrade
|
Revenue as Reported | - | 7,693 | 6,183 | 5,380 | 6,243 | Upgrade
|
Advertising Expenses | - | 0.39 | 3.73 | 0.97 | 0.67 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.